Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Market Reports & Share Ideas
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Market Reports & Share Ideas
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Tags
Ondine Biomedical
Tag:
Ondine Biomedical
Shares
AIM weekly movers: EnergyPathways disappointment
Andrew Hore
-
17/08/2025
3
Shares
AIM movers: Tower Resources rig contract and Great Western Mining funding for Nevada exploration
Andrew Hore
-
10/06/2025
2
Shares
AIM movers: Tracsis tap-in technology rail deal and Jet2 load factors dip
Andrew Hore
-
19/02/2025
0
Shares
AIM movers: Good Energy recommends bid and Ondine Biomedical cash injection delayed
Andrew Hore
-
27/01/2025
1
Shares
AIM movers: SDX Energy postpones general meeting and Arecor Therapeutics licence deal
Andrew Hore
-
30/12/2024
0
Shares
AIM movers: Ondine Biomedical raises money at a premium and Itim breaks even in the first half
Andrew Hore
-
24/09/2024
0
Shares
AIM movers: Ondine Biomedical NHS breakthrough and Getech continues to fall
Andrew Hore
-
21/06/2024
1
Shares
AIM movers: Kibo Mining restructuring and Safestay buys Brighton property
Andrew Hore
-
07/06/2024
0
Shares
AIM movers: Premium fundraising for Ondine Biomedical and Roadside Real Estate gets more from stake sale
Andrew Hore
-
03/05/2024
1
Shares
AIM movers: Gelion testing success and ex-dividends
Andrew Hore
-
04/04/2024
0
1
2
Page 1 of 2
Most Read
AIM movers: ImmuPharma cash raising and CRISM Therapeutics orphan designation
17/03/2026
FTSE 100 gains as defensive names rally
17/03/2026
Gattaca: next Tuesday’s results should see shares improve
17/03/2026
Raising a Lobster: How OpenClaw Reshapes China’s AI Market
17/03/2026